Moroney J T, Tang M X, Berglund L, Small S, Merchant C, Bell K, Stern Y, Mayeux R
Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, College of Physicians and Surgeons and Columbia-Presbyterian Medical Center, New York, NY 10032, USA.
JAMA. 1999 Jul 21;282(3):254-60. doi: 10.1001/jama.282.3.254.
Next to Alzheimer disease, vascular dementia is the second most common form of dementia in the elderly, yet few specific risk factors have been identified.
To investigate the relationship of plasma lipids and lipoproteins to dementia with stroke.
Prospective longitudinal community-based study over a 7-year period (1991-1998).
A total of 1111 nondemented participants (mean [SD] age, 75.0 [5.9] years) were followed up for an average of 2.1 years (range, 1-7.8 years).
Incident dementia with stroke according to standardized criteria, by baseline levels of total plasma cholesterol and triglycerides, low-density lipoprotein (LDL) cholesterol, LDL levels corrected for lipoprotein(a), high-density lipoprotein cholesterol, lipoprotein(a), and apolipoprotein E genotype.
Two hundred eighty-six (25.7%) of the 1111 subjects developed dementia during follow-up; 61 (21.3%) were classified as having dementia with stroke and 225 (78.7%) as having probable Alzheimer disease. Levels of LDL cholesterol were significantly associated with an increased risk of dementia with stroke. Compared with the lowest quartile, the highest quartile of LDL cholesterol was associated with an approximately 3-fold increase in risk of dementia with stroke, adjusting for vascular risk factors and demographic variables (relative risk [RR], 3.1; 95% confidence interval [CI], 1.5-6.1). Levels of LDL corrected for lipoprotein(a) were an even stronger predictor of dementia with stroke in the adjusted multivariate analysis. Compared with the lowest quartile, the RR of dementia with stroke for the highest quartile of lipoprotein(a)-corrected LDL cholesterol was 4.1 (95% CI, 1.8-9.6) after adjusting for vascular factors and demographic variables. Lipid or lipoprotein levels were not associated with the development of Alzheimer disease in our cohort.
Elevated levels of LDL cholesterol were associated with the risk of dementia with stroke in elderly patients. Further study is needed to determine whether treatment of elevated LDL cholesterol levels will reduce the risk of dementia with stroke.
在老年人中,血管性痴呆是仅次于阿尔茨海默病的第二常见的痴呆形式,但已确定的特定危险因素很少。
研究血浆脂质和脂蛋白与卒中后痴呆的关系。
一项为期7年(1991 - 1998年)的基于社区的前瞻性纵向研究。
共有1111名非痴呆参与者(平均[标准差]年龄,75.0[5.9]岁),平均随访2.1年(范围,1 - 7.8年)。
根据标准化标准,依据血浆总胆固醇、甘油三酯、低密度脂蛋白(LDL)胆固醇、经脂蛋白(a)校正的LDL水平、高密度脂蛋白胆固醇、脂蛋白(a)以及载脂蛋白E基因型的基线水平,确定卒中后新发痴呆情况。
1111名受试者中有286名(25.7%)在随访期间发生痴呆;61名(21.3%)被归类为卒中后痴呆,225名(78.7%)可能患有阿尔茨海默病。LDL胆固醇水平与卒中后痴呆风险增加显著相关。与最低四分位数相比,LDL胆固醇最高四分位数与卒中后痴呆风险增加约3倍相关,校正血管危险因素和人口统计学变量后(相对风险[RR],3.1;95%置信区间[CI],1.5 - 6.1)。在调整后的多变量分析中,经脂蛋白(a)校正的LDL水平是卒中后痴呆更强的预测指标。校正血管因素和人口统计学变量后,与最低四分位数相比,经脂蛋白(a)校正的LDL胆固醇最高四分位数的卒中后痴呆RR为4.1(95%CI,1.8 - 9.6)。在我们的队列中,脂质或脂蛋白水平与阿尔茨海默病的发生无关。
老年患者中LDL胆固醇水平升高与卒中后痴呆风险相关。需要进一步研究以确定降低LDL胆固醇水平是否会降低卒中后痴呆风险。